Cognitive enhancement. Current status and its impact on improving of the performance of organizations

Misun, Juraj and Hudakova, Ivana (2011): Cognitive enhancement. Current status and its impact on improving of the performance of organizations. Published in: Knowledge - economy - society : challenges of the contemporary world / Renata Oczkowska, Bogusz Mikuła (eds.) (2011): pp. 157-165.

Abstract

From the Western countries a new dangerous phenomenon is approaching the Central and Eastern Europe. The pressure on psychical performance while studying and at work is becoming that hard that many individuals are reaching for stimulants. When cigarettes, coffee and energy drinks do not help anymore, the next in row are compulsory prescription drugs, which have been developed for entirely different purposes and which can sometimes have far-reaching lifelong consequences for the health. This phenomenon is called brain doping or cognitive enhancement.

• Item Type: MPRA Paper
• Language: English
• Keywords: Cognitive enhancement. Productivity. Brain doping.
• Subjects: I - Health, Education, and Welfare > I1 - Health > I19 - Other; M - Business Administration and Business Economics ; Marketing ; Accounting ; Personnel Economics > M5 - Personnel Economics > M59 - Other

References

Harris, S. (Society for Neuroscience): New research finds that the common arguments against the development of cognitive enhancers are misguided? The Doping Journal. Vol. 2, No. 3 (2005). Originally published 14 November, 2005. ISSN 1812-948X. Available at: http://dopingjournal.org/content/2/3/

Helmchen, H. – Sartorius, N.: Ethics in Psychiatry: European Contributions. International Library of Ethics, Law, and the New Medicine – 45th Edition. Heidelberg: Springer, 2010. ISBN 978-90-481-8720-1. 573 pp.

Moore, E. A.: The Amphetamine Debate: The Use of Adderall, Ritalin and Related Drugs for Behavior Modification, Neuroenhancement and Anti-Aging Purposes. McFarland Health Topics – 10th Edition. Jefferson: McFarland, 2010. ISBN 0-7864-5873-8. pp. 240.

Groß, D.: Neuro-Enhancement unter besonderer Berücksichtigung neurobionischer Maßnahmen. Anmerkungen aus ethischer sicht. in Wienke, A. – Eberbach, W. H. – Kramer, H.-J. – Janke, K.: Die Verbesserung des Menschen: Tatsächliche und rechtliche Aspekte der wunscherfüllenden Medizin. Springer, 2009. ISBN 978-3-642-00882-5. pp. 88

Schöne-Seifert, B. – Talbot, D.: Neuro Enhancement – Ethik vor neuen Herausforderungen. 1. Auflage. Paderborn: Mentis, 2009. ISBN 978-3-8-9785602-8. pp. 367.

Morein-Zamir, S. – Robbins, T. – Turner, D. – Sahakian, B. J.: Pharmacological cognitive enhancement. in Cooper, C. L. – Goswami, U. –Sahakian, B. J.: Mental Capital and Wellbeing. John Wiley and Sons, 2009. ISBN 978-1-4051-8591-2. pp. 1040.